Can-Fite BioPharma (CANF) Enterprise Value: -4.811M

Can-Fite BioPharma Ltd. (CANF)

1.90 -0.10 (-5.00%) USD | NYAM | Oct 09, 16:00

1.91 +0.01 (+0.53%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2012. Start Trial.

Date	Value
October 09, 2026	-4.811M
October 08, 2026	-4.597M
October 07, 2026	-4.383M
October 06, 2026	-4.297M
October 05, 2026	-4.297M
October 02, 2026	-4.207M
October 01, 2026	-4.147M
September 30, 2026	-4.168M
September 29, 2026	-4.211M
September 28, 2026	-4.104M
September 25, 2026	-4.250M
September 24, 2026	-4.233M
September 23, 2026	-4.254M
September 22, 2026	-4.104M
September 21, 2026	-4.126M
September 18, 2026	-4.083M
September 17, 2026	-4.083M
September 16, 2026	-4.083M
September 15, 2026	-4.083M
September 14, 2026	-3.954M
September 11, 2026	-3.89M
September 10, 2026	-4.254M
September 09, 2026	-4.190M
September 08, 2026	-3.976M
September 04, 2026	-4.104M

Date	Value
September 03, 2026	-3.847M
September 02, 2026	-3.826M
September 01, 2026	-1.833M
August 31, 2026	-2.069M
August 28, 2026	-1.598M
August 27, 2026	-1.662M
August 26, 2026	-1.769M
August 25, 2026	-1.769M
August 24, 2026	-1.705M
August 21, 2026	-1.748M
August 20, 2026	-1.705M
August 19, 2026	-1.426M
August 18, 2026	-1.490M
August 17, 2026	-1.212M
August 14, 2026	-1.598M
August 13, 2026	-1.598M
August 12, 2026	-1.512M
August 11, 2026	-1.790M
August 10, 2026	-2.005M
August 07, 2026	-1.512M
August 06, 2026	-1.255M
August 05, 2026	-2.026M
August 04, 2026	-2.047M
August 03, 2026	-2.090M
July 31, 2026	-2.133M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks